Atlas Trials

Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer

Clinical trial NCT01373294 · COMPLETED

Trial details

NCT number
NCT01373294
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2011-11-30
Primary completion
2015-01-09
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.